See also this year's filing and all EDGAR filings for this company.
PDF Report 0001114220_2015_Keryx_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Regenerx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001114220, Keryx Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 98,596,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,208,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,532,000 |
| 3 | remainder_Assets | 292,000 |
| 4 | LiabilitiesCurrent | 29,311,000 |
| 5 | LiabilitiesNoncurrent | 133,000 |
| 6 | remainder_Liabilities | 700,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 70,057,000 |
| 9 | ResearchAndDevelopmentExpense | 51,502,000 |
| 10 | remainder_Expenses | 1,195,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 11,236,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 103,628,000 |
| 1 | Liabilities | 30,144,000 |
| 2 | Expenses | 122,754,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 73,484,000 |
| 5 | NetIncome | -111,518,000 |
| 6 | ComprehensiveNetIncome | -111,518,000 |
| 7 | BaseVar | 133,881,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.728 |
| 9 | EconomicCapitalRatio | 2.08 |
Edgar->Model Mapping
Feature Distribution
Change over Time
